F. Schenck

发表

Aviscumine (ME-503)-Skin Reaction as significant Factor for its Efficacy Expanded Evaluation of the Results from the Phase II Trial NCT00658437 in Patients with Unresectable stage IV Metastatic Melanoma

K. Kähler, R. Gutzmer, V. Jacobi, 2017 .

The basophil activation test is a helpful diagnostic tool in anaphylaxis to sesame with false‐negative specific IgE and negative skin test

B. Wedi, A. Kapp, U. Raap, 2011, Allergy.

Therapeutic use of erythropoietin in dermatooncology

F. Thol, A. Ganser, R. Gutzmer, 2007, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial.

M. Weichenthal, C. Berking, A. Hauschild, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

The hand‐foot‐syndrome associated with medical tumor therapy – classification and management

M. Alter, R. Gutzmer, A. Degen, 2010, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study

K. Kähler, R. Gutzmer, V. Jacobi, 2014, Journal of Immunotherapy for Cancer.

Prognostic Significance of Isolated HMB45 or Melan A Positive Cells in Melanoma Sentinel Lymph Nodes

R. Gutzmer, A. Kapp, I. Satzger, 2007, The American journal of surgical pathology.

Lentivirus-induced ‘Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma

C. von Kalle, R. Gutzmer, F. Farzaneh, 2015, Gene Therapy.

Spontaneous regression of melanoma with distant metastases - report of a patient with brain metastases.

R. Gutzmer, A. Kapp, I. Satzger, 2006, European journal of dermatology : EJD.

Dupilumab Treatment of Atopic Dermatitis in Routine Clinical Care: Baseline Characteristics of Patients in the PROLEAD Prospective, Observational Study

M. Augustin, D. Thaçi, R. von Kiedrowski, 2022, Dermatology and Therapy.

Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low‐dose interferon alpha

A. Hauschild, R. Gutzmer, A. Kapp, 2007, International journal of cancer.

Anal Mucosal Melanoma with KIT-Activating Mutation and Response to Imatinib Therapy – Case Report and Review of the Literature

R. Gutzmer, A. Kapp, I. Satzger, 2009, Dermatology.

Comparison of classification systems in melanoma sentinel nodes: An analysis of 697 patients from a single center.

R. Gutzmer, I. Satzger, F. Schenck, 2010 .

Perception of the coronavirus pandemic by patients with atopic dermatitis – Results from the TREATgermany registry

K. Schäkel, E. Haufe, A. Heratizadeh, 2021, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis

M. Augustin, D. Thaçi, R. von Kiedrowski, 2023, Dermatology and Therapy.

Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate‐to‐severe atopic dermatitis

K. Schäkel, W. Lieb, E. Haufe, 2023, Allergy.